<DOC>
	<DOC>NCT02732548</DOC>
	<brief_summary>This study is being conducted to collect data on the performance of Miromatrix Wound Matrix (MIRODERM) when used in the treatment of complex wounds in an inpatient setting.</brief_summary>
	<brief_title>MIRODERM™ for Complex Wounds in an Inpatient Setting (MIRODERM CLOSure)</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<criteria>Be at least 18 years old Have a complex study wound which will require an autograft or delayed primary closure procedure and which may or may not include tunneling and/or undermining Have a study wound with a total postdebridement surface area ≥50cm2 and ≤250cm2 with no dimension &gt;25cm, and a minimum depth of ≥0.5cm Have a study wound which is expected to take at least 4 weeks to reach autograft or delayed primary closure using standard care and NPWT Have a study wound that will be treated with NPWT regardless of study participation Be in an inpatient setting Be able and willing to sign the consent form and comply with all study visits and procedures Be pregnant or be planning to become pregnant during the study Be contraindicated for NPWT (necrotic tissue with eschar present, untreated osteomyelitis, nonenteric and unexplored fistulas, malignancy in the wound, exposed vasculature, exposed nerves, exposed anastomotic site, exposed organs) Be immunocompromised or at risk of immunosuppression (e.g. be HIV positive, be experiencing organ rejection, be a recent, current, or anticipated chemotherapy recipient) as determined by the Investigator Be taking a Tumor Necrosis Factor (TNF) blocker Be participating in another research study Have a sensitivity to porcine material Have a life expectancy of less than 1 year Have a study wound which is a third degree burn wound Have a study wound that is infected Have a study wound that is a pressure ulcer/wound Have a study wound with sinus tract(s) leading to other open area(s) Have a wound that is being treated or expected to be treated with either HBOT or topical wound oxygen therapy Have a study wound which has been treated with a cellular and/or tissuebased product within last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>